<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nuclear factor-kappaB (NF-kappaB) is involved in multiple aspects of <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> and controls <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell survival by promoting anti-apoptotic gene expression </plain></SENT>
<SENT sid="1" pm="."><plain>The constitutive activation of NF-kappaB in several types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, including <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e>, has been implicated in the resistance to chemo- and radiation therapy </plain></SENT>
<SENT sid="2" pm="."><plain>We have previously reported that cytokine- or virus-induced NF-kappaB activation is inhibited by chemical and physical inducers of the heat shock response (HSR) </plain></SENT>
<SENT sid="3" pm="."><plain>In this study we show that heat stress inhibits constitutive NF-kappaB DNA-binding activity in different types of B-cell <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, including <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo>, activated B-cell-like (ABC) type of diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) and Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> presenting aberrant NF-kappaB regulation </plain></SENT>
<SENT sid="4" pm="."><plain>Heat-induced NF-kappaB inhibition leads to rapid downregulation of the anti-apoptotic protein cellular inhibitor-of-<z:mpath ids='MPATH_3'>apoptosis</z:mpath> protein 2 (cIAP-2), followed by activation of caspase-3 and cleavage of the caspase-3 substrate poly(<z:chebi fb="0" ids="37463">adenosine diphosphate ribose</z:chebi>)polymerase (PARP), causing massive <z:mpath ids='MPATH_3'>apoptosis</z:mpath> under conditions that do not affect viability in cells not presenting NF-kappaB aberrations </plain></SENT>
<SENT sid="5" pm="."><plain>NF-kappaB inhibition by the <z:chebi fb="0" ids="52726">proteasome inhibitor</z:chebi> <z:chebi fb="0" ids="52717">bortezomib</z:chebi> and by short-hairpin <z:chebi fb="40" ids="33697">RNA</z:chebi> (shRNA) interference results in increased sensitivity of HS-Sultan B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> to hyperthermic stress </plain></SENT>
<SENT sid="6" pm="."><plain>Altogether, the results indicate that aggressive B-cell <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> presenting constitutive NF-kappaB activity are sensitive to heat-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and suggest that aberrant NF-kappaB regulation may be a marker of heat stress sensitivity in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
</text></document>